Cargando…
Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
BACKGROUND: BCG is a prototypal cancer immunotherapeutic factor currently approved of bladder cancer. In attempt to further enhance the effectiveness of immunotherapy of bladder cancer and, potentially, other malignancies, we evaluated the impact of BCG on local production of chemokines attracting t...
Autores principales: | Muthuswamy, Ravikumar, Wang, Liwen, Pitteroff, Jamie, Gingrich, Jeffrey R, Kalinski, Pawel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371844/ https://www.ncbi.nlm.nih.gov/pubmed/25806105 http://dx.doi.org/10.1186/s40425-015-0050-8 |
Ejemplares similares
-
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx
por: Gandhi, Shipra, et al.
Publicado: (2023) -
Synergistic induction of cancer-related immunosuppression by β2-adrenergic stress mediators and P38MAPK inflammatory pathway
por: Muthuswamy, Ravikumar, et al.
Publicado: (2013) -
IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients
por: Wong, Jeffrey L, et al.
Publicado: (2013) -
IL-18-based combinatorial adjuvants promote the NK-DC-mediated production of the CCR7 ligand CCL19 in lymph nodes from cancer patients
por: Wong, Jeffrey L, et al.
Publicado: (2013) -
IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation
por: Hamouda, Ahmed E. I., et al.
Publicado: (2022)